Regencell Bioscience (RGC) had the highest return on September 17, 2024 by a mid-cap US stock, returning 22.1%.

ASSET	DATE	% RETURN
Regencell Bioscience (RGC)	9/17/2024	22.13%
Telesat (TSAT)	9/17/2024	8.26%
Youdao (DAO)	9/17/2024	7.33%
GDS (GDS)	9/17/2024	7.15%
Upstart Holdings (UPST)	9/17/2024	6.95%
Sprint Communications (S)	9/17/2024	6.09%
Excelerate Energy (EE)	9/17/2024	6.05%
GigaCloud Technology Inc Class A Ordinary Shares (GCT)	9/17/2024	5.94%
Oceaneering International (OII)	9/17/2024	5.81%
Enphase Energy (ENPH)	9/17/2024	5.79%
Edgewise Therapeutics (EWTX)	9/17/2024	5.64%
Solaris Energy Infrastructure (SEI)	9/17/2024	5.21%
Herc (HRI)	9/17/2024	5.09%
Celsius (CELH)	9/17/2024	5.07%
Bread Financial (BFH)	9/17/2024	5.02%
Butterfly Network (BFLY)	9/17/2024	4.92%
Iovance Biotherapeutics (IOVA)	9/17/2024	4.83%
Rhythm Pharmaceuticals (RYTM)	9/17/2024	4.77%
Construction Partners (ROAD)	9/17/2024	4.67%
Bausch + Lomb (BLCO)	9/17/2024	4.62%
Skeena Resources (SKE)	9/17/2024	4.57%
ZIM Integrated Shipping Services (ZIM)	9/17/2024	4.45%
BitVentures (BVC)	9/17/2024	4.3%
Cactus (WHD)	9/17/2024	4.16%
PHINIA (PHIN)	9/17/2024	3.82%

Mid-cap stocks are treated as having a market cap between $2B and $10B.